Spring direct naar de hoofdnavigatie of de inhoud
‘My aim is to increase the value of your company by aligning intellectual property with corporate strategy.’
Jetze Beeksma

Jetze Beeksma

  • Life Sciences
  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner

Jetze Beeksma studied Molecular Biology & Biotechnology and Law at the University of Groningen. During his studies he did an internship at a law firm in Amsterdam, where he looked into the scope of protection conferred by patents on nucleic acids. Jetze also worked in the IP department of an international law firm in Amsterdam.

Continue reading

Jetze advises on patent matters in the field of life sciences. His work includes the drafting, and worldwide prosecution, of patent applications relating to biotechnological inventions. He further assesses validity, scope of protection and infringement of patents, and advises in contentious patent proceedings.

In his capacity as European Patent Litigator, Jetze is allowed to act as UPC representative.

Working experience

  • Patent attorney, V.O. (2014-present)

Education

  • MSc in Molecular Biology & Biotechnology, University of Groningen (cum laude)
  • LLM in Law, University of Groningen, University of Groningen (cum laude)

Directories

  • “Recently, pharmaceutical litigation by patent attorneys such as Jetze Beeksma and Martin Klok for research-based industry has dominated more than in previous years. Both partners are stars in the Dutch patent scene” (JUVE Patent 2024)
  • Recommended individual (JUVE Patent 2020, 2021, 2022, 2023, 2024)
  • “The life sciences group had an exceptionally strong year thanks to the meteoric rise of Jetze Beeksma, who was lead counsel for the technical aspects of Moderna’s litigation against Pfizer and BioNTech in the Dutch proceedings over mRNA vaccines” (JUVE Patent 2023)
  • “We appreciate the team’s high-quality work. They are very responsive and, most of all, easy to work with (Jetze Beeksma)” (Managing IP, 2023)
  • “He is doing a great job on the originator side” (JUVE Patent 2022)
  • Recognized as ‘Rising Star’ (2020, 2021, 2022, 2023, 2024, 2025) by Managing IP
  • “Very good in pharmaceuticals, definitely a younger patent attorney to have an eye on in the future” (JUVE Patent 2020)

Languages

  • Dutch
  • English

Also see these experts

Marijke Westra

Marijke Westra

  • European and Dutch Patent Attorney, European Patent Litigator
  • Senior Associate
Leen Beller

Leen Beller

  • European and Dutch Patent Attorney
  • Associate
More experts

News

Your patent portfolio in safe hands: timely payment of annual fees

Your patent is a valuable intellectual asset that protects the core of your innovation and competitive advantage. Maintaining that protection is essential and requires meticulous management. An important aspect, for example, is the periodic timely payment of annual fees. Missing a payment deadline can lead to complications, additional costs and, in the worst case, even […]Continue reading

Awards for innovation

The importance of innovation was emphasised again this year by the awarding of the 2025 Nobel Prize in Chemistry and the ‘Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel’ — often referred to as the Nobel Prize in Economics.Continue reading

Book​​​​​​​ ‘Experimental Use and Bolar ­Exemptions’

Recently, the book Experimental Use and Bolar Exemptions (ISBN 9789403518695) was published in the AIPPI Law series. It provides a comparative overview for legislators, lawyers, and companies on the scope of patent protection, with a focus on two important exceptions: the exemption for experimental use and the Bolar exemption.Continue reading